Dolman Life Science Services

Dohmen Life Science Services was a U.S. life science services company that provided outsourced commercialization and support services to biopharma and medical device manufacturers rather than developing therapeutics of its own. Its offerings spanned regulatory consulting, market access, specialty distribution, patient support, technology, supply chain, finance and compliance services across the product lifecycle. The business was built as a services platform serving hundreds of BioPharma and MedTech innovators, with particular strength in specialty, rare and complex therapies. In 2018, Dohmen Life Science Services was acquired by Water Street Healthcare Partners and JLL Partners and subsequently combined with other service providers into EVERSANA. As a standalone company, it is no longer active under the Dohmen Life Science Services brand.